Skip to main content
Equibles
ALTO logo

ALTO · Alto Ingredients, Inc. · Metrics

Track ALTO — free

Use ALTO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ALTO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.66 -0.06 (-1.61%) Q2 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$283.90M
Shares
77.57M
Volume · Oct 28 866.69K Avg daily vol (3M) 1.39M

ALTO metrics

101 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$3.66
Market cap
$283.90M

Price action

20 metrics
Price change (1W)
+4.5%
Price change (30D)
+1.4%
Price change (3M)
-16.4%
Price change (6M)
-29.5%
Price change (YTD)
+29.2%
Price change (1Y)
+250.9%
Trailing year
Price change (5Y)
-27.3%
52-week high
$5.99
52-week low
$1.01
Change from 52-week high
-37.9%
Change from 52-week low
+268.3%
Annualized volatility
92.8%
Annualized volatility (3M)
45.6%
Beta
0.3
RSI (14D)
49.8
Price vs SMA 50
-3.7%
Price vs SMA 200
-12.8%
Avg volume (3M)
1.41M
Relative volume
0.8
Average dollar volume
$5.81M

Company

3 metrics
Sector
Basic Materials
Industry
Specialty Chemicals
Shares outstanding
77.57M

Valuation

12 metrics
P / E (TTM)
5.6
Trailing earnings · reciprocal yield 18.0%
PEG ratio
—
EV / revenue
0.3×
reciprocal yield 286.6%
EV / EBITDA
5.4×
reciprocal yield 18.5%
EV / EBIT
9.2×
reciprocal yield 10.8%
P / sales
0.3×
reciprocal yield 326.9%
P / book
1.1
reciprocal yield 90.1%
FCF yield
17.3%
TTM · current market cap
Buyback yield
1.3%
P / FCF
5.8
reciprocal yield 17.3%
P / operating cash flow
4.4
reciprocal yield 22.5%
Earnings yield
18.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
17.8×
reciprocal yield 5.6%
EV / revenue historical average (3Y)
0.2×
reciprocal yield 412.7%
EV / revenue historical average (5Y)
0.3×
reciprocal yield 383.2%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
22.4×
reciprocal yield 4.5%
EV / EBITDA historical average (3Y)
259.2×
reciprocal yield 0.4%
EV / EBITDA historical average (5Y)
259.2×
reciprocal yield 0.4%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
1.3%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
6.8%
Operating margin
3.8%
Trailing 12 months
Net margin
5.5%
Gross profit (TTM)
$64.51M
Operating profit (TTM)
$35.61M
Net income (TTM)
$51.99M
Trailing 12 months
Diluted EPS (TTM)
$0.67
FCF margin
5.3%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$12.26
Gross profit per diluted share (TTM)
$0.84
Operating profit per diluted share (TTM)
$0.47
EBITDA per diluted share (TTM)
$0.80
Net income per diluted share (TTM)
$0.67
Operating cash flow per diluted share (TTM)
$0.85
Free cash flow per diluted share (TTM)
$0.65
Capital expenditures per diluted share (TTM)
$0.20
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.04
Book value per share
$3.17

Growth

11 metrics
Revenue growth YoY
+12.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$943.33M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+3.3%
Year over year · more shares
Revenue CAGR (3Y)
-11.8%
Revenue CAGR (5Y)
+0.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
-33.2%

Quality

14 metrics
Return on equity
20.0%
Return on assets
13.1%
Debt / equity
0.2
Current ratio
3.2
EBITDA (TTM)
$61.01M
Free cash flow (TTM)
$49.94M
Quick ratio
2.2
Interest coverage
3.8
Net debt / EBITDA
0.7
Return on invested capital
—
Trailing 12 months
Net cash
−$40.57M
Latest balance sheet
Cash & equivalents
$23.96M
Total assets
$397.07M
Total debt
$64.53M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$65.01M
Capital expenditures (TTM)
$15.07M
R&D (TTM)
—
SG&A (TTM)
$28.56M
Stock compensation (TTM)
$3.07M
R&D / revenue
—
Stock compensation / revenue
0.3%

Ownership (13F)

9 metrics
13F filers
134
13F filer change QoQ
+31
Institutional ownership
49.0%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
17.2%
Private-fund adviser ownership
16.2%
Active holders' share change QoQ
-14.1%
Holder tenure
9.4
Price vs estimated holder cost
+39.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
9.8%

Short interest

3 metrics
Short interest
7.2%
Latest settlement · 5.8 days to cover
Days to cover
5.8d
Short-squeeze score
58 / 100

Insider activity

2 metrics
Net insider buying (90D)
$246,799
Insider-sentiment score
84 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 778164 CUSIP 021513106 13F (30d) 16 filings 16 filers Visit website Investor relations